Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
CALL
Visa
V
$714B
| $14M | 0.02% |
89,400
+62,100
| +227% | +$8.95M |
|
1027
PUT
Cognizant
CTSH
$28B
| $14M | 0.02% |
192,600
+187,000
| +3,339% | +$13.1M |
|
1028
Teladoc Health
TDOC
$1.13B
| $13.9M | 0.02% |
250,351
-657,031
| -72% | -$40.1M |
|
|
AFMD
1029
DELISTED
Affimed
AFMD
| $13.9M | 0.02% |
331,146
+18,955
| +6% | +$682K |
|
1030
CALL
Stryker
SYK
$126B
| $13.9M | 0.02% |
70,400
+35,400
| +101% | +$6.37M |
|
1031
CALL
NVIDIA
NVDA
$5.05T
| $13.9M | 0.02% |
3,092,000
+1,140,000
| +58% | +$4.42M |
|
1032
Regeneron Pharmaceuticals
REGN
$85.3B
| $13.9M | 0.02% |
33,768
+16,033
| +90% | +$6.6M |
|
|
PRO
1033
DELISTED
PROS Holdings
PRO
| $13.9M | 0.02% |
328,005
+2,584
| +0.8% | +$98.1K |
|
|
CSGS
1034
DELISTED
CSG Systems International
CSGS
| $13.9M | 0.02% |
327,492
+94,133
| +40% | +$3.64M |
|
1035
HUB Group
HUBG
$2.46B
| $13.8M | 0.02% |
677,902
+43,378
| +7% | +$925K |
|
|
CVRS
1036
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $13.8M | 0.02% |
7,951,964
+863,272
| +12% | +$1.19M |
|
1037
Warner Bros
WBD
$72B
| $13.8M | 0.02% |
511,980
-1,112,727
| -68% | -$31M |
|
1038
CALL
Centene
CNC
$32.4B
| $13.8M | 0.02% |
260,000
+180,000
| +225% | +$10.9M |
|
|
PXD
1039
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $13.8M | 0.02% |
90,500
-235,800
| -72% | -$33.3M |
|
1040
Nu Skin
NUS
$232M
| $13.8M | 0.02% |
287,850
+25,546
| +10% | +$1.55M |
|
|
SIEN
1041
DELISTED
Sientra, Inc.
SIEN
| $13.7M | 0.02% |
159,666
+63,055
| +65% | +$7.06M |
|
1042
Infosys
INFY
$47.9B
| $13.6M | 0.02% |
1,248,263
+1,139,737
| +1,050% | +$12.1M |
|
1043
Kemper
KMPR
$1.63B
| $13.6M | 0.02% |
178,862
+109,422
| +158% | +$8.39M |
|
1044
Old National Bancorp
ONB
$9.86B
| $13.6M | 0.02% |
+829,624
| New | +$13.9M |
|
1045
iShares MSCI Indonesia ETF
EIDO
$491M
| $13.6M | 0.02% |
529,053
+134,754
| +34% | +$3.55M |
|
1046
Urban Edge Properties
UE
$2.73B
| $13.6M | 0.02% |
714,722
+45,242
| +7% | +$874K |
|
1047
Sempra
SRE
$55.3B
| $13.6M | 0.02% |
215,592
-1,034,720
| -83% | -$61M |
|
1048
Stellantis
STLA
$19.7B
| $13.6M | 0.02% |
912,540
-1,263,195
| -58% | -$19.4M |
|
1049
Lattice Semiconductor
LSCC
$16.2B
| $13.5M | 0.02% |
1,134,954
+844,222
| +290% | +$8.42M |
|
|
AVLR
1050
DELISTED
Avalara, Inc.
AVLR
| $13.5M | 0.02% |
242,409
+157,143
| +184% | +$7.29M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.